Clinical Trials Browser

Phase 3 × INDUSTRY × Autoimmune Diseases × Clear all

NCT07039916 2026-05-22

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

Phase 3 Recruiting

Autoimmune Diseases, Myasthenia Gravis

NCT05737160 2025-05-23

Study of Telitacicept in Generalized Myasthenia Gravis

Phase 3 Completed

Autoimmune Diseases, Myasthenia Gravis, Muscle Weakness

NCT01210716 2013-09-23

Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device

Phase 3 Completed

37 enrolled 7 charts

Autoimmune Diseases, Hematologic Diseases, Kidney Diseases, Nervous System Diseases, Paraproteinemias